Actively Recruiting
Risk Factors and Outcomes in Coronary Chronic Total Occlusion
Led by Ruijin Hospital · Updated on 2024-11-18
3000
Participants Needed
1
Research Sites
895 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to assess the risk factors and evaluate the long-term outcomes of patients with coronary chronic total occlusion (CTO) treated with percutaneous coronary intervention or medical treatment.
CONDITIONS
Official Title
Risk Factors and Outcomes in Coronary Chronic Total Occlusion
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Patients with angina or silent ischemia and documented ischemia
- Patients with coronary chronic total occlusion (CTO) lasting 3 months or more
You will not qualify if you...
- Estimated glomerular filtration rate (eGFR) less than 15 mL/(min·1.73m2)
- Chronic heart failure with New York Heart Association (NYHA) grade 3 or higher
- History of coronary artery bypass grafting
- Percutaneous coronary intervention within the prior 3 months
- Malignant tumor or immune system disorders
- Pulmonary heart disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, China
Actively Recruiting
Research Team
F
Fenghua Ding, PhD, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here